<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-104">
 <label>104</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Monahan</surname>
    <given-names>PE</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Gui</surname>
    <given-names>T</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial.</article-title>
  <source>
   <italic>Hum Gene Ther.</italic>
  </source>
  <year>2015</year>;
  <volume>26</volume>(
  <issue>2</issue>):
  <fpage>69</fpage>â€“
  <lpage>81</lpage>. 
  <pub-id pub-id-type="doi">10.1089/hum.2014.106</pub-id>
  <!--<pub-id pub-id-type="pmcid">4326268</pub-id>-->
  <?supplied-pmid 25419787?>
  <pub-id pub-id-type="pmid">25419787</pub-id>
 </mixed-citation>
</ref>
